欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6564/001
药品名称Fampridin-ratiopharm 10 mg Retardtabletten
活性成分
    • fampridine 10.0 mg
剂型Prolonged-release tablet
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Fampridin-ratiopharm 10 mg Retardtabletten
互认成员国 - 产品名称
    • Lithuania (LT)
      Fampridine Teva 10 mg pailginto atpalaidavimo tabletės
    • Czechia (CZ)
      Fampridin Teva
    • Slovakia (SK)
      Fampridín Teva 10 mg tablety s predĺženým uvoľňovaním
    • Slovenia (SI)
    • Croatia (HR)
      Fampridin Teva 10 mg tablete s produljenim oslobađanjem
    • Denmark (DK)
      Fampridin "Teva"
    • Netherlands (NL)
      Fampridine Teva 10 mg, tabletten met verlengde afgifte
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Norway (NO)
      Fampridin Teva
    • Poland (PL)
许可日期2021/07/14
最近更新日期2023/08/25
药物ATC编码
    • N07XX07 fampridine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase